Search research articles
Contact Us
Filters
Showing results (41-50 of 130) with videos related to
Page
of 13
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 12, 2013
Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve
Jan N Basile, Michael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 8, 2009
Analysis of recent papers in hypertension. Lack of legacy effect with more intensive blood pressure control in the long-term follow-up of the United Kingdom Prospective Diabetes Study
Michael J Bloch, Jan N Basile
Postgraduate Medicine
|
March 6, 2010
Identifying and managing factors that interfere with or worsen blood pressure control
Jan N Basile, Michael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 11, 2010
Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 6, 2007
Analysis of recent papers in hypertension
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 9, 2008
Analysis of recent papers in hypertension
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 19, 2009
Analysis of Recent Papers in Hypertension
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 9, 2009
In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND)
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 31, 2012
NHANES data highlight the clinical characteristics of those with poorly controlled hypertension
Jan N Basile, Michael J Bloch
Journal of the American Society of Hypertension : JASH
|
December 15, 2015
Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come
Michael J Bloch, Jan N Basile
Page
of 13
Search research articles
Search
Showing results (41-50 of 130) with videos related to
Sort By:
Page
of 13
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 12, 2013
Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve
Jan N Basile, Michael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 8, 2009
Analysis of recent papers in hypertension. Lack of legacy effect with more intensive blood pressure control in the long-term follow-up of the United Kingdom Prospective Diabetes Study
Michael J Bloch, Jan N Basile
Postgraduate Medicine
|
March 6, 2010
Identifying and managing factors that interfere with or worsen blood pressure control
Jan N Basile, Michael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 11, 2010
Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 6, 2007
Analysis of recent papers in hypertension
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 9, 2008
Analysis of recent papers in hypertension
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 19, 2009
Analysis of Recent Papers in Hypertension
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 9, 2009
In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND)
Michael J Bloch, Jan N Basile
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 31, 2012
NHANES data highlight the clinical characteristics of those with poorly controlled hypertension
Jan N Basile, Michael J Bloch
Journal of the American Society of Hypertension : JASH
|
December 15, 2015
Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come
Michael J Bloch, Jan N Basile
Page
of 13